jn – -Translation – Keybot Dictionary

Spacer TTN Translation Network TTN TTN Login Deutsch Français Spacer Help
Source Languages Target Languages
Keybot 10 Results  www.hivnet.ubc.ca
  Research Publications |...  
Balfour L, Spaans JN, Fergusson D, Huff H, Mills EJ, la Porte CJ, Walmsley S, Singhai N, Rosenes R, Tremblay N, Gill MJ, Loemba H, Conway B, Rachlis A, Ralph E, Loutfy M, Mallick R, Moorhouse R, William Cameron D. Micronutrient deficiency and treatment adherence in a randomized controlled trial of micronutrient supplementation in ART-naïve persons with HIV.
Althoff KN, Rebeiro P, Brooks JT, Buchacz K, Gebo K, Martin J, Hogg R, Thorne JE, Klein M, Gill MJ, Sterling TR, Yehia B, Silverberg MJ, Crane H, Justice AC, Gange SJ, Moore R, Kitahata MM, Horberg MA, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Disparities in the quality of HIV care when using US department of health and human services indicators. Clin Infect Dis. 2014 Apr;58(8):1185-9.
  CTN 238: The MAINTAIN s...  
Balfour L, Spaans JN, Fergusson D, Huff H, Mills EJ, la Porte CJ, Walmsley SL, Singhal N, Rosenes R, Tremblay N, Gill MJ, Loemba H, Conway B, Rachlis A, Ralph E, Loutfy MR, Mallick R, Moorhouse R, Cameron DW.
Balfour L, Spaans JN, Fergusson D, Huff H, Mills EJ, la Porte CJ, Walmsley SL, Singhal N, Rosenes R, Tremblay N, Gill MJ, Loemba H, Conway B, Rachlis A, Ralph E, Loutfy MR, Mallick R, Moorhouse R, William Cameron D. Micronutrient deficiency and treatment adherence in a randomized controlled trial of micronutrient supplementation in ART-naïve persons with HIV. PLOS ONE. 2014;9(1):e85607.
  CTN 173: Vaccination be...  
Spaans JN, Routy JP, Tremblay CL, Singer J, Bernard N, Gurunathan S, Sékaly RP, Angel JB. Optimizing the efficiency of therapeutic HIV vaccine trials: a case for CTN 173. Trials in Vaccinology. 2012;1:21-26.
Spaans JN, Routy JP, Tremblay CL, Singer J, Bernard N, Gurunathan S, Sékaly RP, Angel JB.Optimizing the efficiency of therapeutic HIV vaccine trials: a case for CTN 173. Trials in Vaccinology. 2012;1:21-26.
  CTN 205: Valproic acid ...  
Routy JP, Angel JB, Spaans JN, Trottier B, Rouleau D, Baril JG, Harris M, Trottier S, Singer J, Chomont N, Sékaly RP, Tremblay CL. Design and implementation of a randomized crossover study of valproic acid and antiretroviral therapy to reduce the HIV reservoir.
Routy JP, Angel JB, Spaans JN, Trottier B, Rouleau D, Baril JG, Harris M, Trottier S, Singer J, Chomont N, Sékaly RP, Tremblay CL. Design and implementation of a randomized crossover study of valproic acid and antiretroviral therapy to reduce the HIV reservoir. HIV Clin Trials. 2012;13(6):301-307.